We found that overexpression of AP-2α significantly increased glioma cell apoptosis and synergistically enhanced the cytotoxicity of TMZ, which was in concomitant with decreased expression of Survivin, a critical drug resistance regulator, and the downstream gene MDR-1. This evidence concerns the gene ABCB1 and central nervous system cancer.